Report: Medical Inflation, Drug Spending Among Top Comp Concerns

The workers’ compensation industry is poised to see a pivotal shift in pharmaceutical spending, as 2023 marked the first time in recent history that opioid dispensing didn’t land in the top spot of therapeutic classes, according to the 2024 Enlytened Trends Report released Tuesday by Enlyte LLC. The annual report, which assesses top issues faced by the property and casualty insurance industry, also highlighted medical cost and inflation trends in workers’ compensation, along with physician and provider shortages. On the drug front, topicals in 2023 represented 18.5% of...